Pipeline

We build a world-class pipeline by proprietary discovery platforms. Our innovation engine has been validated by clinical assets and global partnerships.

Get in Touch →

You are here: Home » Pipeline » PRE-CLINICAL

PHASE 3
PHASE 2
PHASE 1
PRE-CLINICAL

PRE-CLINICAL

BSI-093

Target / Modality: BTN3A Agonist
Indication: AML
Status: IND filing 26Q4
Partner(territory right): Available for partnerhip

PRE-CLINICAL

BSI-532

Target / Modality: IL7R x IL4R
Indication: SA/AD/COPD
Status: IND filing 26Q3
Partner(territory right): Available for partnerhip

PRE-CLINICAL

BSI-730

Target / Modality: HER2 × PD-L1 bispecific ADC
Indication: Solid Tumors
Status: Pre-clinical
Partner(territory right): Available for partnerhip

Find us in China, Hong Kong SAR, the United States & Australia

Quick Links

- BD@Biosion.com
- +1-302-998-5126
- +86-25-5829-1977